WE GIVE SHAREHOLDERS A VOICE
The complaint alleges that Antares Pharma, Inc. violated federal securities laws by issuing materially false and/or misleading information and/or failing to disclose material information.
If you suffered a loss in Antares Pharma, Inc. you have until 2017-12-22 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.